BRADLEY WILLIAM 4

What Happened
Bradley William, a director of Fractyl Health, made an open-market purchase of 68,493 shares at $0.73 per share on 2026-06-10 for a total of $50,329. On the same date he was also granted a 22,500-share stock option award (derivative) valued at $0.00 in the filing.

Key Details

• Transaction date(s): 2026-06-10; Filing date: 2026-06-11 (appears timely).
• Open-market purchase (code P): 68,493 shares @ $0.73 = $50,329. (Footnote F1: open market purchase.)
• Award/grant (code A): 22,500-share option award @ $0.00 (derivative). (Footnote F2: non-employee director compensation.)
• Vesting for the option award: vests in a single installment on the earlier of the next annual meeting or one year from grant, subject to continued board service.
• Shares owned after the transaction: not specified in the information provided.

Context
The purchase is an outright open-market buy (direct equity purchase), which some investors view as a stronger signal than awards, though filings do not reveal motive. The 22,500-share item is an awarded option that will vest in the future if the director remains in service; it is not an immediate exercise or sale.